Hip Abductor Function During Trendelenburg Test

Last updated: July 21, 2023
Sponsor: Ahram Canadian University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Sarcopenia

Polymyositis (Inflammatory Muscle Disease)

Treatment

Trendelenburg hip abduction test

Clinical Study ID

NCT05967611
OT-TT-001
  • Ages 18-45
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This study will use electromyography and dynamometry to evaluate gluteal muscle activation during the Trendelenburg hip abduction test in different hip positions.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Healthy adults aged 18-45 years
  • No history of hip disorders

Exclusion

Exclusion Criteria:

  • Contraindications to EMG
  • Neurological or muscular disorders

Study Design

Total Participants: 30
Treatment Group(s): 1
Primary Treatment: Trendelenburg hip abduction test
Phase:
Study Start date:
July 25, 2023
Estimated Completion Date:
December 28, 2023

Study Description

The Trendelenburg test is commonly used to assess hip abductor weakness. However, it is unclear which hip position during this test best isolates gluteal muscle function. This study will measure gluteus medius and minimus activation and hip abduction force in 30 healthy participants performing the Trendelenburg test. Different hip flexion, extension, adduction and abduction angles will be evaluated to determine which position optimally targets the gluteal muscles. Results may enhance utilization of the Trendelenburg test in clinical practice.

Connect with a study center

  • Outpatient clinic of faculty of physical therapy, Ahram Canadian University

    Al Ḩayy Ath Thāmin, Giza 3221405
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.